DNLI
Price
$21.34
Change
+$0.42 (+2.01%)
Updated
Dec 26, 04:59 PM (EDT)
67 days until earnings call
SEER
Price
$2.20
Change
-$0.01 (-0.45%)
Updated
Dec 26, 04:59 PM (EDT)
63 days until earnings call
Ad is loading...

DNLI vs SEER

Header iconDNLI vs SEER Comparison
Open Charts DNLI vs SEERBanner chart's image
Denali Therapeutics
Price$21.34
Change+$0.42 (+2.01%)
Volume$12.3K
CapitalizationN/A
Seer
Price$2.20
Change-$0.01 (-0.45%)
Volume$2.16K
CapitalizationN/A
DNLI vs SEER Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. SEER commentary
Dec 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and SEER is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Dec 27, 2024
Stock price -- (DNLI: $20.92 vs. SEER: $2.21)
Brand notoriety: DNLI and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 30% vs. SEER: 59%
Market capitalization -- DNLI: $3.07B vs. SEER: $129.14M
DNLI [@Biotechnology] is valued at $3.07B. SEER’s [@Biotechnology] market capitalization is $129.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.39B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, SEER is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while SEER’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 5 bearish.
  • SEER’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both DNLI and SEER are a bad buy in the short-term.

Price Growth

DNLI (@Biotechnology) experienced а -9.91% price change this week, while SEER (@Biotechnology) price change was -6.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.71%. For the same industry, the average monthly price growth was +0.43%, and the average quarterly price growth was +6.36%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

SEER is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (+6.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.07B) has a higher market cap than SEER($129M). SEER YTD gains are higher at: 13.918 vs. DNLI (-2.516). SEER has higher annual earnings (EBITDA): -92.7M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. SEER (248M). SEER has less debt than DNLI: SEER (26.5M) vs DNLI (52.5M). SEER has higher revenues than DNLI: SEER (14.2M) vs DNLI (0).
DNLISEERDNLI / SEER
Capitalization3.07B129M2,378%
EBITDA-496.05M-92.7M535%
Gain YTD-2.51613.918-18%
P/E RatioN/AN/A-
Revenue014.2M-
Total Cash837M248M338%
Total Debt52.5M26.5M198%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLISEER
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
79%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCTRX48.310.57
+1.19%
Goldman Sachs US Tax-Managed Eq R6
TRACX17.030.14
+0.83%
PGIM Quant Solutions Small-Cap Val C
RSSRX26.830.21
+0.79%
Victory RS Select Growth R6
IFACX24.160.12
+0.50%
American Funds Income Fund of Amer C
NRIFX21.340.05
+0.23%
Nuveen Real Asset Income R6

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+0.67%
BEAM - DNLI
64%
Loosely correlated
+0.38%
NTLA - DNLI
54%
Loosely correlated
-0.41%
LGND - DNLI
54%
Loosely correlated
-0.37%
CRSP - DNLI
52%
Loosely correlated
+1.14%
RCKT - DNLI
51%
Loosely correlated
+2.19%
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
-1.78%
AXON - SEER
56%
Loosely correlated
+1.14%
ARRY - SEER
47%
Loosely correlated
-3.28%
PMVP - SEER
43%
Loosely correlated
-2.65%
DNLI - SEER
38%
Loosely correlated
+0.67%
BEAM - SEER
38%
Loosely correlated
+0.38%
More